Postmenopausal change in MSCs sensitivity to testosterone, 17β-estradiol, and PTH are associated with impaired adipogenesis
Bulletin of Russian State Medical University · 16.04.2026 · (2)
DOI: 10.24075/brsmu.2026.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Russian State Medical University, online erschienen am 16.04.2026. Verfasst von AA Zinoveva und 8 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
The menopausal transition is accompanied by the decrease in estrogen levels and changes in the estrogen to androgen ratio, resulting in dysregulation of multipotent mesenchymal stem cell (MSCs) differentiation in the subcutaneous adipose tissue, reduction of their adipogenic potential, adipocyte hypertrophy, and metabolic disorder progression. Menopausal hormone therapy (MHT) is used to manage menopausal symptoms. However, the effects of exogenous hormones on MSCs are still poorly understood. The study aimed to assess adipogenic differentiation of the subcutaneous adipose tissue MSCs and their sensitivity to testosterone, 17β-estradiol, and parathyroid hormone (PTH) in postmenopause. A total of six patients with benign gynecological disorders were included in the study, among them two were of reproductive age, one was perimenopausal, and three were postmenopausal. The MSCs adipogenic differentiation was performed throughout 14 days with the addition of testosterone, 17β-estradiol, or PTH, 10 nM each, then the proportion of cells containing lipid droplets was assessed. The adipogenesis level in control samples was 26–30% in patients of childbearing age and 12–42% in postmenopausal ones, with the pronounced interindividual variability. Hormonal stimulation considerably suppressed MSCs adipogenesis in postmenopause: testosterone reduced adipogenesis to 46–56% of control levels, estradiol to 51–84%, PTH to 53–66%, while patients of childbearing age showed a less pronounced effect (65–85%). The obtained data demonstrate a shift in hormonal sensitivity of MSCs from subcutaneous adipose tissue in postmenopause and suggest that MHT may exert an additional inhibiting effect on adipogenesis through suppression of MSCs differentiation.
Zitieren
APA
Zinoveva, A., Bakhchinian, E., Kamenkov, S., Shcherbakova, L., Bugerenko, A., Ogay, D., Voloshin, N., Chechekhina, E., & Kulebyakin, K. (2026). Postmenopausal change in MSCs sensitivity to testosterone, 17β-estradiol, and PTH are associated with impaired adipogenesis. Bulletin of Russian State Medical University. https://doi.org/10.24075/brsmu.2026.013
Vancouver
Zinoveva A, Bakhchinian E, Kamenkov S, Shcherbakova L, Bugerenko A, Ogay D, et al. Postmenopausal change in MSCs sensitivity to testosterone, 17β-estradiol, and PTH are associated with impaired adipogenesis. Bulletin of Russian State Medical University. 2026. doi:10.24075/brsmu.2026.013
BibTeX
@article{Zinoveva2026,
author = {Zinoveva, AA and Bakhchinian, E and Kamenkov, SS and Shcherbakova, LN and Bugerenko, AE and Ogay, DS and Voloshin, NS and Chechekhina, ES and Kulebyakin, KYu},
title = {Postmenopausal change in MSCs sensitivity to testosterone, 17β-estradiol, and PTH are associated with impaired adipogenesis},
journal = {Bulletin of Russian State Medical University},
year = {2026},
number = {2},
doi = {10.24075/brsmu.2026.013}
}
EUVIMED